These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36064745)

  • 21. Uptake of COVID-19 vaccination among people who inject drugs.
    Iversen J; Wand H; Kemp R; Bevan J; Briggs M; Patten K; Heard S; Maher L
    Harm Reduct J; 2022 Jun; 19(1):59. PubMed ID: 35655217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of COVID-19 vaccine uptake among people who inject drugs.
    Strathdee SA; Abramovitz D; Vera CF; Artamonova I; Patterson TL; Smith DM; Chaillon A; Bazzi AR
    Vaccine; 2023 Mar; 41(12):1916-1924. PubMed ID: 36697311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 vaccination acceptability and experiences among people who inject drugs in San Diego County.
    Valasek CJ; Streuli SA; Pines HA; Mittal ML; Strathdee SA; Vera CF; Harvey-Vera A; Bazzi AR
    Prev Med Rep; 2022 Dec; 30():101989. PubMed ID: 36148319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. M
    Martel-Laferrière V; Feaster DJ; Metsch LR; Schackman BR; Loignon C; Nosyk B; Tookes H; Behrends CN; Arruda N; Adigun O; Goyer ME; Kolber MA; Mary JF; Rodriguez AE; Yanez IG; Pan Y; Khemiri R; Gooden L; Sako A; Bruneau J
    Trials; 2022 Apr; 23(1):341. PubMed ID: 35461260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in the San Diego-Tijuana border region.
    Strathdee SA; Abramovitz D; Harvey-Vera A; Vera CF; Rangel G; Artamonova I; Chaillon A; Ignacio C; Calderon A; Martin NK; Patterson TL
    PLoS One; 2021; 16(11):e0260286. PubMed ID: 34807963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlates of Coronavirus Disease 2019 (COVID-19) Vaccine Hesitancy Among People Who Inject Drugs in the San Diego-Tijuana Border Region.
    Strathdee SA; Abramovitz D; Harvey-Vera A; Vera CF; Rangel G; Artamonova I; Patterson TL; Mitchell RA; Bazzi AR
    Clin Infect Dis; 2022 Aug; 75(1):e726-e733. PubMed ID: 35024825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Home-based hepatitis C self-testing in people who inject drugs and men who have sex with men in Georgia: a protocol for a randomised controlled trial.
    Shilton S; Stvilia K; Japaridze M; Tsereteli N; Usharidze D; Phevadze S; Jghenti M; Mozalevskis A; Markby J; Luhmann N; Johnson C; Nabeta P; Ongarello S; Reipold EI; Gamkrelidze A
    BMJ Open; 2022 Sep; 12(9):e056243. PubMed ID: 36691209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computerized Tailored Interventions to Enhance Prevention and Screening for Hepatitis C Virus Among People Who Inject Drugs: Protocol for a Randomized Pilot Study.
    Westergaard RP; Hull SJ; Merkow A; Stephens LK; Hochstatter KR; Olson-Streed HK; Baker LM; Hess TM
    JMIR Res Protoc; 2016 Jan; 5(1):e15. PubMed ID: 26800903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
    Urwyler P; Charitos P; Moser S; Heijnen IAFM; Trendelenburg M; Thoma R; Sumer J; Camacho-Ortiz A; Bacci MR; Huber LC; Stüssi-Helbling M; Albrich WC; Sendi P; Osthoff M
    Trials; 2021 Jan; 22(1):1. PubMed ID: 33397449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
    Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of Ayurvedic interventions and Yoga on long term effects of COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Yadav B; Rai A; Mundada PS; Singhal R; Rao BCS; Rana R; Srikanth N
    Trials; 2021 Jun; 22(1):378. PubMed ID: 34082792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing COVID-19 testing and vaccination among Spanish speakers in the USA: protocol for the development and evaluation of the
    Rhodes SD; Tanner AE; Mann-Jackson L; Alonzo J; Hall MA; Bertoni AG; McCoy TP; Aguilar-Palma SK; Garcia M; Miranda D; Turner MJ
    BMJ Open; 2022 Nov; 12(11):e066585. PubMed ID: 36385019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial.
    Olagunju A; Fowotade A; Olagunoye A; Ojo TO; Adefuye BO; Fagbamigbe AF; Adebiyi AO; Olagunju OI; Ladipo OT; Akinloye A; Adeagbo BA; Onayade A; Bolaji OO; Happi C; Rannard S; Owen A
    Trials; 2021 Jan; 22(1):3. PubMed ID: 33397457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a Cannabis Harm Reduction Intervention for People With First-Episode Psychosis: Protocol for a Pilot Multicentric Randomized Trial.
    Coronado-Montoya S; Abdel-Baki A; Côté J; Crockford D; Dubreucq S; Fischer B; Lachance-Touchette P; Lecomte T; L'Heureux S; Ouellet-Plamondon C; Roy MA; Tatar O; Tibbo P; Villeneuve M; Wittevrongel A; Jutras-Aswad D
    JMIR Res Protoc; 2023 Dec; 12():e53094. PubMed ID: 38109196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
    Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.